Kneu Health: making an international impact in neurology 

Kneu Health (formerly Neu Health), a University of Oxford spinout, delivers AI-powered digital health solutions for neurology, focusing on Parkinson’s and dementia. This FDA-cleared, UKCA-marked platform integrates a patient app and clinician dashboard. Backed by 10 years of research, it partners with major charities and won the 2024 HSJ Digitising Patient Care Award. 

Ushering in a new era of proactive neurology care 

Kneu Health addresses critical challenges in neurology: long waits, fragmented care and a lack of objective data. Focused on Parkinson’s and dementia, it enables a shift from reactive, hospital-based models to proactive, digital, community care. The platform empowers patients through self-management tools and supports clinicians with real-time data, aligning with NHS priorities – digitising services, managing long-term conditions, and relieving workforce pressures. Kneu Health reduces admissions, supports prevention, and frees up specialists to deliver more with existing resources.  

Kneu Health was born from both personal experience and clinical insight. Co-founder and CEO Caroline Cake witnessed the complexities and fragmentation of dementia care through her mother and grandmother’s journeys with dementia, which highlighted the urgent need for more effective, personalised support. Co-founder and Chief Medical Officer Dr Kinan Muhammed, a leading Oxford neurologist, brings a wealth of clinical expertise and understanding of the need to utilise data to transform neurology services.  

Kneu Health provides a platform that combines digital biomarkers with AI to enable real-time, remote monitoring and proactive care. Over 700 hours of co-design with patients, caregivers and clinicians ensured the platform is both clinically robust and highly usable.

Key challenges in this space have previously included digital access, workflow integration, and regulatory compliance. With Kneu Health, each has been addressed through collaboration and iteration. Today, Kneu Health is deployed across NHS and US systems, empowering patients and clinicians alike with timelier, data-driven support for long-term neurological conditions.

The DigitalHealth.London Accelerator: bringing together perspectives 

Kneu Health joined the Accelerator programme, aiming to expand their innovation’s real-world impact, strengthen partnerships, and refine their pathway into wider NHS adoption. They believe that the programme has offered invaluable support. This includes facilitating introductions to NHS stakeholders and amplifying their visibility through curated events. 

We would recommend the Accelerator programme for any health tech founder – it provides critical insight, access, and structure to scale innovations responsibly and effectively across complex healthcare systems. 

With DigitalHealth.London’s guidance, Kneu Health sharpened their value proposition, demonstrating not just clinical and operational benefits, but alignment with health priorities like the Elective Recovery Plan, Patient-Initiated Follow-Up (PIFU) and NHS Long Term Plan. The mentorship helped refine their strategy for tackling health inequalities and digital barriers to access. 

Being part of the Accelerator also profoundly shaped Kneu Health’s leadership perspective, encouraging collaborative, patient-centred design and reinforcing the value of real-world evidence. As a result, the company won the Health Ecosystem Impact award at the 2025 DigitalHealth.London Showcase: Celebrating Innovation event.

Developing a case for positive change 

Neu Health has delivered strong outcomes across clinical, operational and patient experience metrics. Over 1,700 patients are now supported, with clinicians reporting improved care in 90% of cases. 53% of patients had their care plans changed due to insights from Neu Health’s dashboard, often involving optimised medication or earlier interventions. 

Economic analysis shows £2,345 savings per patient annually, with national potential exceeding £200m. Clinics using Neu Health achieved 20% efficiency gains and 31% time savings. Half of the patients were identified as suitable for Patient-Initiated Follow-Up, enabling better triage and reduced visits. 

Patients using the app over six months reported a 27% increase in condition knowledge, a 15% boost in confidence, and 17% greater empowerment. These improvements in education and self-management are key to long-term condition management. 

Key partnerships include Parkinson’s UK and the Alzheimer’s Society, supporting awareness and adoption across new demographics and care settings.

International growth and success 

Kneu Health is expanding rapidly across the UK and internationally, with deployments in 11 NHS hospital sites and two US health systems. Their work in London has been strongly supported by the London Growth Programme, which offered tailored commercial guidance and introduced them to strategic partners. The DigitalHealth.London Accelerator further enabled Kneu Health to access NHS pathways, improve interoperability planning, and share their learnings through ‘high-impact’ showcases. 

In parallel, Kneu Health’s participation in the Alzheimer’s Society Accelerator has been crucial in their dementia expansion. They are one of only two innovations selected in 2025, benefitting from direct user engagement, condition-specific insights and deeper reach into dementia care networks. These programmes helped shape and validate the Kneu Health approach for cognitive accessibility, caregiver support and integration with mental health trusts and primary care. 

Through these partnerships, Kneu Health is now scaling digital-first dementia care – bridging care gaps, improving outcomes and supporting national objectives for ageing, prevention and remote monitoring. 

Kneu Health’s next goal is to continue to expand their Parkinson’s pathway across UK multi-site systems to demonstrate scalable, geographically diverse impact. They are also growing dementia pilots and establishing primary care partnerships to support the full care continuum, from GP practices through to specialist services.  

Kneu Health welcomes collaborations with NHS trusts, ICSs and commissioners ready to pioneer digital-first neurology care. If you’re driving transformation in Parkinson’s or dementia, they’d love to explore future partnerships. Get in touch to learn more.   

Learn more about Kneu Health by visiting their website and connecting on LinkedIn.

Kneu Health is part of cohort 8 of the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator programme is funded by the UK Government via the UK Shared Prosperity Fund (UKSPF). It is delivered by the Health Innovation Network (HIN) South London in partnership with the Office of Life Sciences, CW+, Medicity, NHS England, the Mayor of London and the Levelling Up Fund.

For more information, please visit https://www.gov.uk/government/publications/uk-
shared-prosperity-fund-prospectus.